Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
CPI and the University of Liverpool formalise partnership
We’ve signed a Memorandum of Understanding (MoU) with the University of Liverpool to boost research and innovation partnerships in Liverpool City Region.
Mar 10 2022
News
North East ageing and tech experts launch project to support businesses in innovating for the ageing population
A project between CPI, the National Innovation Centre for Ageing and the North of Tyne Combined Authority will improve wellbeing through tech innovation.
Mar 09 2022
Blog
Meet the Team: Becky Fields, Marketing and Communications Business Partner
Our Meet the Team blog series celebrates our incredible people from across CPI.
Mar 08 2022
Blog
Careers in STEM: Mona Gayle-Jinadu
Looking at careers in STEM, here we focus on Mona Gayle-Jinadu, an IChemE Award winner, Process Engineering Team Leader, and Deputy Safety Lead at CPI.
Mar 07 2022
News
Welcoming four new appointments to our Board
Catherine Quinn, George Gillespie, Jez Maiden, and Myrtle Dawes join CPI’s board as Non-Executive members
Mar 01 2022
News
CPI joins partnership to tackle the early diagnosis of Parkinson’s disease
We’ve joined a new partnership to develop a scaled manufacturing process for α‑synuclein protein to support the early diagnosis of Parkinson’s disease.
Feb 24 2022
Blog
The future of the pharma industry can be sustainable
The pharmaceutical industry has a big sustainability problem. We’re supporting progress in this industry with the implementation of digital technologies.
Feb 24 2022
News
CPI part of North East LEP investment to grow region’s battery sector
The North East Local Enterprise Partnership has awarded more than £90k to expand the work of a partnership that will grow the North East’s battery sector.
Feb 18 2022
News
GSK Director joins CPI as Director of Biologics
We’re delighted to welcome Brendan Fish who will join CPI as Director of Biologics in May to support the scale-up and commercialisation of biologics
